atropine has been researched along with paliperidone in 1 studies
| Studies (atropine) | Trials (atropine) | Recent Studies (post-2010) (atropine) | Studies (paliperidone) | Trials (paliperidone) | Recent Studies (post-2010) (paliperidone) |
|---|---|---|---|---|---|
| 26,711 | 1,259 | 1,697 | 24 | 0 | 17 |
| Protein | Taxonomy | atropine (IC50) | paliperidone (IC50) |
|---|---|---|---|
| D(2) dopamine receptor | Homo sapiens (human) | 0.0083 | |
| 5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 0.0052 | |
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 1.2344 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
1 review(s) available for atropine and paliperidone
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |